nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE6H—pineal body—malignant glioma	0.0246	0.0723	CbGeAlD
Dipyridamole—PDE6A—retina—malignant glioma	0.0132	0.0389	CbGeAlD
Dipyridamole—PDE6C—retina—malignant glioma	0.0126	0.0369	CbGeAlD
Dipyridamole—Tonic-clonic seizures—Carmustine—malignant glioma	0.0115	0.0672	CcSEcCtD
Dipyridamole—PDE6B—retina—malignant glioma	0.00796	0.0234	CbGeAlD
Dipyridamole—PRUNE—telencephalon—malignant glioma	0.00771	0.0226	CbGeAlD
Dipyridamole—PDE6D—telencephalon—malignant glioma	0.00744	0.0219	CbGeAlD
Dipyridamole—PDE6H—retina—malignant glioma	0.0074	0.0217	CbGeAlD
Dipyridamole—PDE6B—telencephalon—malignant glioma	0.00732	0.0215	CbGeAlD
Dipyridamole—PDE6G—retina—malignant glioma	0.00712	0.0209	CbGeAlD
Dipyridamole—Grand mal convulsion—Carmustine—malignant glioma	0.00651	0.038	CcSEcCtD
Dipyridamole—PDE1C—midbrain—malignant glioma	0.00614	0.018	CbGeAlD
Dipyridamole—Transient ischaemic attack—Temozolomide—malignant glioma	0.00594	0.0347	CcSEcCtD
Dipyridamole—PDE5A—endothelium—malignant glioma	0.00579	0.017	CbGeAlD
Dipyridamole—PDE6B—medulla oblongata—malignant glioma	0.00575	0.0169	CbGeAlD
Dipyridamole—PDE6D—midbrain—malignant glioma	0.00535	0.0157	CbGeAlD
Dipyridamole—PDE5A—blood vessel—malignant glioma	0.00534	0.0157	CbGeAlD
Dipyridamole—PDE6B—midbrain—malignant glioma	0.00526	0.0154	CbGeAlD
Dipyridamole—PDE6B—spinal cord—malignant glioma	0.00513	0.0151	CbGeAlD
Dipyridamole—PDE1C—central nervous system—malignant glioma	0.00486	0.0143	CbGeAlD
Dipyridamole—PDE1C—cerebellum—malignant glioma	0.00475	0.0139	CbGeAlD
Dipyridamole—PDE2A—telencephalon—malignant glioma	0.00443	0.013	CbGeAlD
Dipyridamole—PDE10A—telencephalon—malignant glioma	0.00443	0.013	CbGeAlD
Dipyridamole—PDE1B—telencephalon—malignant glioma	0.00439	0.0129	CbGeAlD
Dipyridamole—PRUNE—cerebellum—malignant glioma	0.00428	0.0126	CbGeAlD
Dipyridamole—PDE8B—telencephalon—malignant glioma	0.00422	0.0124	CbGeAlD
Dipyridamole—PDE6B—central nervous system—malignant glioma	0.00416	0.0122	CbGeAlD
Dipyridamole—PDE1A—brainstem—malignant glioma	0.00414	0.0122	CbGeAlD
Dipyridamole—PDE6D—cerebellum—malignant glioma	0.00414	0.0121	CbGeAlD
Dipyridamole—PDE6B—cerebellum—malignant glioma	0.00407	0.012	CbGeAlD
Dipyridamole—PDE6H—central nervous system—malignant glioma	0.00387	0.0114	CbGeAlD
Dipyridamole—PDE1C—brain—malignant glioma	0.00386	0.0113	CbGeAlD
Dipyridamole—Injection site pain—Carmustine—malignant glioma	0.0038	0.0222	CcSEcCtD
Dipyridamole—PDE8A—telencephalon—malignant glioma	0.0038	0.0112	CbGeAlD
Dipyridamole—PDE1A—telencephalon—malignant glioma	0.00368	0.0108	CbGeAlD
Dipyridamole—Rigors—Temozolomide—malignant glioma	0.00367	0.0214	CcSEcCtD
Dipyridamole—PDE2A—medulla oblongata—malignant glioma	0.00348	0.0102	CbGeAlD
Dipyridamole—PRUNE—brain—malignant glioma	0.00348	0.0102	CbGeAlD
Dipyridamole—PDE7A—central nervous system—malignant glioma	0.00345	0.0101	CbGeAlD
Dipyridamole—Breast pain—Temozolomide—malignant glioma	0.00344	0.0201	CcSEcCtD
Dipyridamole—PDE6D—brain—malignant glioma	0.00336	0.00987	CbGeAlD
Dipyridamole—PDE6B—brain—malignant glioma	0.0033	0.00971	CbGeAlD
Dipyridamole—PDE2A—midbrain—malignant glioma	0.00318	0.00934	CbGeAlD
Dipyridamole—Coordination abnormal—Carmustine—malignant glioma	0.00316	0.0184	CcSEcCtD
Dipyridamole—PDE2A—spinal cord—malignant glioma	0.0031	0.00911	CbGeAlD
Dipyridamole—Injection site reaction—Carmustine—malignant glioma	0.00308	0.018	CcSEcCtD
Dipyridamole—PDE6H—brain—malignant glioma	0.00307	0.00903	CbGeAlD
Dipyridamole—PDE11A—brain—malignant glioma	0.00307	0.00903	CbGeAlD
Dipyridamole—Coordination abnormal—Temozolomide—malignant glioma	0.00305	0.0178	CcSEcCtD
Dipyridamole—PDE4A—telencephalon—malignant glioma	0.00305	0.00895	CbGeAlD
Dipyridamole—Musculoskeletal pain—Temozolomide—malignant glioma	0.00303	0.0177	CcSEcCtD
Dipyridamole—PDE8B—midbrain—malignant glioma	0.00303	0.00891	CbGeAlD
Dipyridamole—PDE7B—central nervous system—malignant glioma	0.00301	0.00886	CbGeAlD
Dipyridamole—PDE8A—medulla oblongata—malignant glioma	0.00298	0.00877	CbGeAlD
Dipyridamole—PDE1A—medulla oblongata—malignant glioma	0.00289	0.00849	CbGeAlD
Dipyridamole—PDE5A—retina—malignant glioma	0.00282	0.00827	CbGeAlD
Dipyridamole—PDE7A—brain—malignant glioma	0.00274	0.00804	CbGeAlD
Dipyridamole—PDE8A—midbrain—malignant glioma	0.00273	0.00801	CbGeAlD
Dipyridamole—PDE8A—spinal cord—malignant glioma	0.00266	0.00782	CbGeAlD
Dipyridamole—PDE1A—midbrain—malignant glioma	0.00264	0.00776	CbGeAlD
Dipyridamole—PDE5A—telencephalon—malignant glioma	0.00259	0.00761	CbGeAlD
Dipyridamole—PDE1A—spinal cord—malignant glioma	0.00258	0.00757	CbGeAlD
Dipyridamole—ABCC5—retina—malignant glioma	0.00258	0.00757	CbGeAlD
Dipyridamole—Ear pain—Temozolomide—malignant glioma	0.00255	0.0149	CcSEcCtD
Dipyridamole—PDE2A—central nervous system—malignant glioma	0.00252	0.00739	CbGeAlD
Dipyridamole—PDE10A—central nervous system—malignant glioma	0.00252	0.00739	CbGeAlD
Dipyridamole—Eye pain—Carmustine—malignant glioma	0.00249	0.0146	CcSEcCtD
Dipyridamole—PDE1B—central nervous system—malignant glioma	0.00249	0.00733	CbGeAlD
Dipyridamole—PDE2A—cerebellum—malignant glioma	0.00246	0.00722	CbGeAlD
Dipyridamole—PDE10A—cerebellum—malignant glioma	0.00246	0.00722	CbGeAlD
Dipyridamole—PDE1B—cerebellum—malignant glioma	0.00244	0.00716	CbGeAlD
Dipyridamole—Eye pain—Temozolomide—malignant glioma	0.00241	0.0141	CcSEcCtD
Dipyridamole—PDE8B—central nervous system—malignant glioma	0.0024	0.00705	CbGeAlD
Dipyridamole—PDE7B—brain—malignant glioma	0.00239	0.00703	CbGeAlD
Dipyridamole—ABCC5—telencephalon—malignant glioma	0.00237	0.00696	CbGeAlD
Dipyridamole—PDE8B—cerebellum—malignant glioma	0.00235	0.00689	CbGeAlD
Dipyridamole—Hot flush—Temozolomide—malignant glioma	0.00233	0.0136	CcSEcCtD
Dipyridamole—Menopausal symptoms—Temozolomide—malignant glioma	0.00231	0.0135	CcSEcCtD
Dipyridamole—PDE3B—cerebellum—malignant glioma	0.00229	0.00673	CbGeAlD
Dipyridamole—Thirst—Temozolomide—malignant glioma	0.00229	0.0133	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00225	0.0131	CcSEcCtD
Dipyridamole—SLC29A1—telencephalon—malignant glioma	0.00218	0.00639	CbGeAlD
Dipyridamole—PDE8A—cerebellum—malignant glioma	0.00211	0.0062	CbGeAlD
Dipyridamole—PDE1A—central nervous system—malignant glioma	0.00209	0.00614	CbGeAlD
Dipyridamole—PDE1A—cerebellum—malignant glioma	0.00204	0.006	CbGeAlD
Dipyridamole—PDE10A—brain—malignant glioma	0.002	0.00587	CbGeAlD
Dipyridamole—PDE2A—brain—malignant glioma	0.002	0.00587	CbGeAlD
Dipyridamole—PDE1B—brain—malignant glioma	0.00198	0.00582	CbGeAlD
Dipyridamole—Dysphagia—Carmustine—malignant glioma	0.00195	0.0114	CcSEcCtD
Dipyridamole—PDE8B—brain—malignant glioma	0.00191	0.0056	CbGeAlD
Dipyridamole—Dysphagia—Temozolomide—malignant glioma	0.00188	0.011	CcSEcCtD
Dipyridamole—ABCC5—medulla oblongata—malignant glioma	0.00186	0.00547	CbGeAlD
Dipyridamole—PDE3B—brain—malignant glioma	0.00186	0.00547	CbGeAlD
Dipyridamole—Sweating increased—Temozolomide—malignant glioma	0.00183	0.0107	CcSEcCtD
Dipyridamole—ADA—central nervous system—malignant glioma	0.00178	0.00522	CbGeAlD
Dipyridamole—PDE8A—brain—malignant glioma	0.00171	0.00504	CbGeAlD
Dipyridamole—ABCC5—midbrain—malignant glioma	0.0017	0.005	CbGeAlD
Dipyridamole—PDE4A—cerebellum—malignant glioma	0.00169	0.00497	CbGeAlD
Dipyridamole—PDE1A—brain—malignant glioma	0.00166	0.00487	CbGeAlD
Dipyridamole—Haemoglobin—Carmustine—malignant glioma	0.00157	0.00914	CcSEcCtD
Dipyridamole—Haemorrhage—Carmustine—malignant glioma	0.00156	0.00909	CcSEcCtD
Dipyridamole—Hypoaesthesia—Carmustine—malignant glioma	0.00155	0.00905	CcSEcCtD
Dipyridamole—Haemoglobin—Temozolomide—malignant glioma	0.00151	0.00883	CcSEcCtD
Dipyridamole—Haemorrhage—Temozolomide—malignant glioma	0.00151	0.00879	CcSEcCtD
Dipyridamole—Hepatitis—Temozolomide—malignant glioma	0.00151	0.00879	CcSEcCtD
Dipyridamole—Hypoaesthesia—Temozolomide—malignant glioma	0.0015	0.00874	CcSEcCtD
Dipyridamole—Pharyngitis—Temozolomide—malignant glioma	0.00149	0.00872	CcSEcCtD
Dipyridamole—PDE5A—central nervous system—malignant glioma	0.00147	0.00433	CbGeAlD
Dipyridamole—Flushing—Carmustine—malignant glioma	0.00145	0.00844	CcSEcCtD
Dipyridamole—PDE5A—cerebellum—malignant glioma	0.00144	0.00423	CbGeAlD
Dipyridamole—ADA—brain—malignant glioma	0.00141	0.00414	CbGeAlD
Dipyridamole—Tinnitus—Temozolomide—malignant glioma	0.0014	0.00819	CcSEcCtD
Dipyridamole—PDE3A—cerebellum—malignant glioma	0.0014	0.00411	CbGeAlD
Dipyridamole—Cardiac disorder—Temozolomide—malignant glioma	0.0014	0.00816	CcSEcCtD
Dipyridamole—Flushing—Temozolomide—malignant glioma	0.0014	0.00816	CcSEcCtD
Dipyridamole—Arrhythmia—Carmustine—malignant glioma	0.00139	0.00812	CcSEcCtD
Dipyridamole—Alopecia—Carmustine—malignant glioma	0.00138	0.00804	CcSEcCtD
Dipyridamole—PDE4A—brain—malignant glioma	0.00137	0.00404	CbGeAlD
Dipyridamole—Angiopathy—Temozolomide—malignant glioma	0.00137	0.00797	CcSEcCtD
Dipyridamole—Immune system disorder—Temozolomide—malignant glioma	0.00136	0.00794	CcSEcCtD
Dipyridamole—Mediastinal disorder—Temozolomide—malignant glioma	0.00136	0.00792	CcSEcCtD
Dipyridamole—Chills—Temozolomide—malignant glioma	0.00135	0.00789	CcSEcCtD
Dipyridamole—Alopecia—Temozolomide—malignant glioma	0.00133	0.00777	CcSEcCtD
Dipyridamole—ABCC5—cerebellum—malignant glioma	0.00132	0.00387	CbGeAlD
Dipyridamole—Back pain—Carmustine—malignant glioma	0.00131	0.00766	CcSEcCtD
Dipyridamole—Dysgeusia—Temozolomide—malignant glioma	0.00128	0.00749	CcSEcCtD
Dipyridamole—Tremor—Carmustine—malignant glioma	0.00127	0.00742	CcSEcCtD
Dipyridamole—Back pain—Temozolomide—malignant glioma	0.00127	0.0074	CcSEcCtD
Dipyridamole—Anaemia—Carmustine—malignant glioma	0.00125	0.00732	CcSEcCtD
Dipyridamole—SLC29A1—central nervous system—malignant glioma	0.00124	0.00363	CbGeAlD
Dipyridamole—Tremor—Temozolomide—malignant glioma	0.00123	0.00717	CcSEcCtD
Dipyridamole—Ill-defined disorder—Temozolomide—malignant glioma	0.00122	0.0071	CcSEcCtD
Dipyridamole—Anaemia—Temozolomide—malignant glioma	0.00121	0.00707	CcSEcCtD
Dipyridamole—SLC29A1—cerebellum—malignant glioma	0.00121	0.00355	CbGeAlD
Dipyridamole—Angioedema—Temozolomide—malignant glioma	0.0012	0.00699	CcSEcCtD
Dipyridamole—Malaise—Temozolomide—malignant glioma	0.00118	0.0069	CcSEcCtD
Dipyridamole—ABCB1—blood vessel—malignant glioma	0.00118	0.00346	CbGeAlD
Dipyridamole—Vertigo—Temozolomide—malignant glioma	0.00118	0.00687	CcSEcCtD
Dipyridamole—Convulsion—Carmustine—malignant glioma	0.00117	0.00686	CcSEcCtD
Dipyridamole—Hypertension—Carmustine—malignant glioma	0.00117	0.00684	CcSEcCtD
Dipyridamole—PDE5A—brain—malignant glioma	0.00117	0.00343	CbGeAlD
Dipyridamole—Palpitations—Temozolomide—malignant glioma	0.00116	0.00676	CcSEcCtD
Dipyridamole—Chest pain—Carmustine—malignant glioma	0.00115	0.00674	CcSEcCtD
Dipyridamole—Myalgia—Carmustine—malignant glioma	0.00115	0.00674	CcSEcCtD
Dipyridamole—Anxiety—Carmustine—malignant glioma	0.00115	0.00672	CcSEcCtD
Dipyridamole—Cough—Temozolomide—malignant glioma	0.00114	0.00668	CcSEcCtD
Dipyridamole—PDE3A—brain—malignant glioma	0.00114	0.00334	CbGeAlD
Dipyridamole—Convulsion—Temozolomide—malignant glioma	0.00114	0.00663	CcSEcCtD
Dipyridamole—Hypertension—Temozolomide—malignant glioma	0.00113	0.00661	CcSEcCtD
Dipyridamole—Arthralgia—Temozolomide—malignant glioma	0.00112	0.00651	CcSEcCtD
Dipyridamole—Myalgia—Temozolomide—malignant glioma	0.00112	0.00651	CcSEcCtD
Dipyridamole—Anxiety—Temozolomide—malignant glioma	0.00111	0.00649	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00111	0.00647	CcSEcCtD
Dipyridamole—Oedema—Carmustine—malignant glioma	0.00111	0.00646	CcSEcCtD
Dipyridamole—Discomfort—Temozolomide—malignant glioma	0.0011	0.00644	CcSEcCtD
Dipyridamole—Dry mouth—Temozolomide—malignant glioma	0.00109	0.00637	CcSEcCtD
Dipyridamole—Thrombocytopenia—Carmustine—malignant glioma	0.00108	0.00633	CcSEcCtD
Dipyridamole—Tachycardia—Carmustine—malignant glioma	0.00108	0.00631	CcSEcCtD
Dipyridamole—Oedema—Temozolomide—malignant glioma	0.00107	0.00624	CcSEcCtD
Dipyridamole—Anaphylactic shock—Temozolomide—malignant glioma	0.00107	0.00624	CcSEcCtD
Dipyridamole—ABCC5—brain—malignant glioma	0.00107	0.00314	CbGeAlD
Dipyridamole—Nervous system disorder—Temozolomide—malignant glioma	0.00105	0.00612	CcSEcCtD
Dipyridamole—Thrombocytopenia—Temozolomide—malignant glioma	0.00105	0.00611	CcSEcCtD
Dipyridamole—Skin disorder—Temozolomide—malignant glioma	0.00104	0.00607	CcSEcCtD
Dipyridamole—Hypotension—Carmustine—malignant glioma	0.00103	0.00604	CcSEcCtD
Dipyridamole—Hyperhidrosis—Temozolomide—malignant glioma	0.00103	0.00604	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00101	0.00589	CcSEcCtD
Dipyridamole—Paraesthesia—Carmustine—malignant glioma	0.000994	0.0058	CcSEcCtD
Dipyridamole—Dyspnoea—Carmustine—malignant glioma	0.000987	0.00576	CcSEcCtD
Dipyridamole—Somnolence—Carmustine—malignant glioma	0.000984	0.00574	CcSEcCtD
Dipyridamole—SLC29A1—brain—malignant glioma	0.000982	0.00288	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000974	0.00569	CcSEcCtD
Dipyridamole—Paraesthesia—Temozolomide—malignant glioma	0.00096	0.00561	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000955	0.00558	CcSEcCtD
Dipyridamole—Dyspnoea—Temozolomide—malignant glioma	0.000953	0.00557	CcSEcCtD
Dipyridamole—Somnolence—Temozolomide—malignant glioma	0.000951	0.00555	CcSEcCtD
Dipyridamole—Pain—Carmustine—malignant glioma	0.000946	0.00553	CcSEcCtD
Dipyridamole—Dyspepsia—Temozolomide—malignant glioma	0.000941	0.0055	CcSEcCtD
Dipyridamole—ABCC4—central nervous system—malignant glioma	0.000933	0.00274	CbGeAlD
Dipyridamole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000923	0.00539	CcSEcCtD
Dipyridamole—Fatigue—Temozolomide—malignant glioma	0.000922	0.00538	CcSEcCtD
Dipyridamole—Pain—Temozolomide—malignant glioma	0.000914	0.00534	CcSEcCtD
Dipyridamole—Feeling abnormal—Carmustine—malignant glioma	0.000912	0.00532	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Carmustine—malignant glioma	0.000905	0.00528	CcSEcCtD
Dipyridamole—Feeling abnormal—Temozolomide—malignant glioma	0.000881	0.00515	CcSEcCtD
Dipyridamole—Abdominal pain—Carmustine—malignant glioma	0.000875	0.00511	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000874	0.00511	CcSEcCtD
Dipyridamole—Urticaria—Temozolomide—malignant glioma	0.00085	0.00496	CcSEcCtD
Dipyridamole—Abdominal pain—Temozolomide—malignant glioma	0.000845	0.00494	CcSEcCtD
Dipyridamole—Hypersensitivity—Carmustine—malignant glioma	0.000815	0.00476	CcSEcCtD
Dipyridamole—Asthenia—Carmustine—malignant glioma	0.000794	0.00464	CcSEcCtD
Dipyridamole—Hypersensitivity—Temozolomide—malignant glioma	0.000788	0.0046	CcSEcCtD
Dipyridamole—Asthenia—Temozolomide—malignant glioma	0.000767	0.00448	CcSEcCtD
Dipyridamole—Diarrhoea—Carmustine—malignant glioma	0.000757	0.00442	CcSEcCtD
Dipyridamole—Pruritus—Temozolomide—malignant glioma	0.000757	0.00442	CcSEcCtD
Dipyridamole—ABCC4—brain—malignant glioma	0.000741	0.00218	CbGeAlD
Dipyridamole—Dizziness—Carmustine—malignant glioma	0.000732	0.00427	CcSEcCtD
Dipyridamole—Diarrhoea—Temozolomide—malignant glioma	0.000732	0.00427	CcSEcCtD
Dipyridamole—Dizziness—Temozolomide—malignant glioma	0.000707	0.00413	CcSEcCtD
Dipyridamole—Vomiting—Carmustine—malignant glioma	0.000704	0.00411	CcSEcCtD
Dipyridamole—ABCB1—embryo—malignant glioma	0.000703	0.00206	CbGeAlD
Dipyridamole—Rash—Carmustine—malignant glioma	0.000698	0.00407	CcSEcCtD
Dipyridamole—Dermatitis—Carmustine—malignant glioma	0.000697	0.00407	CcSEcCtD
Dipyridamole—Headache—Carmustine—malignant glioma	0.000693	0.00405	CcSEcCtD
Dipyridamole—Vomiting—Temozolomide—malignant glioma	0.00068	0.00397	CcSEcCtD
Dipyridamole—Rash—Temozolomide—malignant glioma	0.000674	0.00394	CcSEcCtD
Dipyridamole—Dermatitis—Temozolomide—malignant glioma	0.000674	0.00393	CcSEcCtD
Dipyridamole—Headache—Temozolomide—malignant glioma	0.00067	0.00391	CcSEcCtD
Dipyridamole—Nausea—Carmustine—malignant glioma	0.000657	0.00384	CcSEcCtD
Dipyridamole—Nausea—Temozolomide—malignant glioma	0.000635	0.00371	CcSEcCtD
Dipyridamole—ABCB1—retina—malignant glioma	0.000621	0.00183	CbGeAlD
Dipyridamole—ABCB1—telencephalon—malignant glioma	0.000572	0.00168	CbGeAlD
Dipyridamole—ABCB1—medulla oblongata—malignant glioma	0.000449	0.00132	CbGeAlD
Dipyridamole—ABCB1—midbrain—malignant glioma	0.00041	0.00121	CbGeAlD
Dipyridamole—ABCB1—spinal cord—malignant glioma	0.0004	0.00118	CbGeAlD
Dipyridamole—ABCB1—central nervous system—malignant glioma	0.000325	0.000954	CbGeAlD
Dipyridamole—ABCB1—cerebellum—malignant glioma	0.000318	0.000933	CbGeAlD
Dipyridamole—ABCB1—brain—malignant glioma	0.000258	0.000758	CbGeAlD
Dipyridamole—PDE1B—Disease—ERBB2—malignant glioma	2.7e-05	5.53e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—malignant glioma	2.7e-05	5.53e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—malignant glioma	2.69e-05	5.51e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—malignant glioma	2.69e-05	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—KRAS—malignant glioma	2.68e-05	5.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CAV1—malignant glioma	2.67e-05	5.48e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CD80—malignant glioma	2.67e-05	5.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CB—malignant glioma	2.67e-05	5.46e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT2—malignant glioma	2.66e-05	5.46e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APC—malignant glioma	2.66e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CG—malignant glioma	2.66e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—BRAF—malignant glioma	2.66e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—malignant glioma	2.66e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—malignant glioma	2.65e-05	5.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—malignant glioma	2.65e-05	5.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—malignant glioma	2.65e-05	5.43e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MYC—malignant glioma	2.64e-05	5.42e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KDR—malignant glioma	2.64e-05	5.41e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—malignant glioma	2.64e-05	5.41e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2B6—malignant glioma	2.64e-05	5.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGF—malignant glioma	2.63e-05	5.39e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—malignant glioma	2.62e-05	5.37e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FGF2—malignant glioma	2.62e-05	5.36e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTPN11—malignant glioma	2.62e-05	5.36e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT2—malignant glioma	2.59e-05	5.31e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.59e-05	5.3e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—malignant glioma	2.59e-05	5.3e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—malignant glioma	2.58e-05	5.28e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CD—malignant glioma	2.56e-05	5.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—F2—malignant glioma	2.55e-05	5.21e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FN1—malignant glioma	2.55e-05	5.21e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PIK3CA—malignant glioma	2.54e-05	5.21e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KRAS—malignant glioma	2.54e-05	5.21e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PIK3CA—malignant glioma	2.54e-05	5.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.53e-05	5.19e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PIK3CA—malignant glioma	2.52e-05	5.16e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PIK3CA—malignant glioma	2.52e-05	5.16e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTEN—malignant glioma	2.52e-05	5.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTEN—malignant glioma	2.52e-05	5.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BAD—malignant glioma	2.52e-05	5.15e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KRAS—malignant glioma	2.51e-05	5.13e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—KRAS—malignant glioma	2.51e-05	5.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—BRAF—malignant glioma	2.5e-05	5.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PTEN—malignant glioma	2.49e-05	5.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOTCH1—malignant glioma	2.49e-05	5.1e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CD—malignant glioma	2.49e-05	5.1e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—malignant glioma	2.48e-05	5.09e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—malignant glioma	2.48e-05	5.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—malignant glioma	2.47e-05	5.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PIK3CA—malignant glioma	2.47e-05	5.05e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—malignant glioma	2.46e-05	5.04e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PIK3CA—malignant glioma	2.46e-05	5.04e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FGF2—malignant glioma	2.45e-05	5.02e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MDM2—malignant glioma	2.45e-05	5.02e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KRAS—malignant glioma	2.44e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RAF1—malignant glioma	2.44e-05	5e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CB—malignant glioma	2.44e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CD80—malignant glioma	2.44e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—malignant glioma	2.44e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—KRAS—malignant glioma	2.44e-05	4.99e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT2—malignant glioma	2.44e-05	4.99e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—malignant glioma	2.44e-05	4.99e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—malignant glioma	2.44e-05	4.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CG—malignant glioma	2.44e-05	4.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APC—malignant glioma	2.44e-05	4.99e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—malignant glioma	2.43e-05	4.97e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—malignant glioma	2.42e-05	4.96e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—malignant glioma	2.42e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB2—malignant glioma	2.41e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—IDH1—malignant glioma	2.41e-05	4.94e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.41e-05	4.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGF—malignant glioma	2.41e-05	4.93e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTPN11—malignant glioma	2.39e-05	4.9e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.39e-05	4.9e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FGF2—malignant glioma	2.38e-05	4.88e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CB—malignant glioma	2.38e-05	4.88e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CD—malignant glioma	2.34e-05	4.79e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SPHK1—malignant glioma	2.34e-05	4.78e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PIK3CA—malignant glioma	2.34e-05	4.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.32e-05	4.75e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PIK3CA—malignant glioma	2.3e-05	4.72e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTEN—malignant glioma	2.3e-05	4.72e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PIK3CA—malignant glioma	2.3e-05	4.72e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MDM2—malignant glioma	2.29e-05	4.7e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—KRAS—malignant glioma	2.29e-05	4.69e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—malignant glioma	2.29e-05	4.69e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BRAF—malignant glioma	2.29e-05	4.69e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2C18—malignant glioma	2.29e-05	4.69e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RAF1—malignant glioma	2.29e-05	4.68e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB2—malignant glioma	2.26e-05	4.63e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—malignant glioma	2.26e-05	4.63e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—malignant glioma	2.25e-05	4.61e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—malignant glioma	2.25e-05	4.61e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PIK3CA—malignant glioma	2.25e-05	4.6e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FGF2—malignant glioma	2.24e-05	4.59e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PIK3CA—malignant glioma	2.24e-05	4.59e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CB—malignant glioma	2.23e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—malignant glioma	2.23e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MDM2—malignant glioma	2.23e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT2—malignant glioma	2.23e-05	4.56e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—malignant glioma	2.23e-05	4.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RAF1—malignant glioma	2.22e-05	4.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—malignant glioma	2.22e-05	4.54e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—malignant glioma	2.22e-05	4.54e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—malignant glioma	2.21e-05	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—malignant glioma	2.21e-05	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB2—malignant glioma	2.2e-05	4.5e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.2e-05	4.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—malignant glioma	2.19e-05	4.49e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—malignant glioma	2.19e-05	4.48e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—malignant glioma	2.17e-05	4.45e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CB—malignant glioma	2.17e-05	4.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—malignant glioma	2.14e-05	4.39e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CD—malignant glioma	2.14e-05	4.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.13e-05	4.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.12e-05	4.34e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTEN—malignant glioma	2.11e-05	4.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—malignant glioma	2.11e-05	4.31e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MDM2—malignant glioma	2.1e-05	4.3e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—malignant glioma	2.1e-05	4.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—malignant glioma	2.09e-05	4.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—malignant glioma	2.09e-05	4.29e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—malignant glioma	2.09e-05	4.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RAF1—malignant glioma	2.09e-05	4.28e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—malignant glioma	2.09e-05	4.27e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—malignant glioma	2.08e-05	4.25e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—malignant glioma	2.07e-05	4.24e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—malignant glioma	2.07e-05	4.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—malignant glioma	2.07e-05	4.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—malignant glioma	2.06e-05	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTEN—malignant glioma	2.06e-05	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—malignant glioma	2.06e-05	4.21e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—malignant glioma	2.06e-05	4.21e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—malignant glioma	2.05e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGF2—malignant glioma	2.05e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—malignant glioma	2.05e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—malignant glioma	2.05e-05	4.19e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—malignant glioma	2.05e-05	4.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—malignant glioma	2.05e-05	4.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CB—malignant glioma	2.04e-05	4.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—malignant glioma	2.03e-05	4.15e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—malignant glioma	2.01e-05	4.13e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—malignant glioma	2.01e-05	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—malignant glioma	2e-05	4.09e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—malignant glioma	1.99e-05	4.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—malignant glioma	1.96e-05	4.02e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—malignant glioma	1.94e-05	3.97e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—malignant glioma	1.93e-05	3.96e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—malignant glioma	1.93e-05	3.96e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTEN—malignant glioma	1.93e-05	3.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—malignant glioma	1.93e-05	3.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—malignant glioma	1.92e-05	3.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MDM2—malignant glioma	1.92e-05	3.93e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—malignant glioma	1.92e-05	3.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—malignant glioma	1.91e-05	3.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RAF1—malignant glioma	1.91e-05	3.91e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—malignant glioma	1.91e-05	3.91e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—malignant glioma	1.89e-05	3.88e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—malignant glioma	1.89e-05	3.87e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—malignant glioma	1.89e-05	3.86e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—malignant glioma	1.88e-05	3.85e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—malignant glioma	1.88e-05	3.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—malignant glioma	1.88e-05	3.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTEN—malignant glioma	1.88e-05	3.84e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—malignant glioma	1.87e-05	3.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—malignant glioma	1.87e-05	3.83e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CB—malignant glioma	1.87e-05	3.82e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—malignant glioma	1.86e-05	3.81e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTT1—malignant glioma	1.85e-05	3.79e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—malignant glioma	1.84e-05	3.77e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—malignant glioma	1.83e-05	3.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—malignant glioma	1.83e-05	3.75e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.8e-05	3.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—malignant glioma	1.79e-05	3.67e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—malignant glioma	1.78e-05	3.64e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—malignant glioma	1.78e-05	3.64e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—malignant glioma	1.77e-05	3.63e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—malignant glioma	1.77e-05	3.62e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTEN—malignant glioma	1.76e-05	3.61e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—malignant glioma	1.76e-05	3.6e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—malignant glioma	1.74e-05	3.57e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS1—malignant glioma	1.73e-05	3.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—malignant glioma	1.73e-05	3.55e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—malignant glioma	1.72e-05	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—malignant glioma	1.72e-05	3.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—malignant glioma	1.72e-05	3.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—malignant glioma	1.71e-05	3.51e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—malignant glioma	1.71e-05	3.5e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—malignant glioma	1.69e-05	3.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—malignant glioma	1.68e-05	3.43e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—malignant glioma	1.67e-05	3.43e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—malignant glioma	1.67e-05	3.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—malignant glioma	1.62e-05	3.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—malignant glioma	1.62e-05	3.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTEN—malignant glioma	1.61e-05	3.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BCHE—malignant glioma	1.61e-05	3.3e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—malignant glioma	1.6e-05	3.28e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—malignant glioma	1.59e-05	3.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC5A5—malignant glioma	1.59e-05	3.26e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—malignant glioma	1.58e-05	3.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—malignant glioma	1.58e-05	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—malignant glioma	1.57e-05	3.22e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—malignant glioma	1.57e-05	3.22e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—malignant glioma	1.57e-05	3.21e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—malignant glioma	1.56e-05	3.19e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—malignant glioma	1.52e-05	3.12e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—malignant glioma	1.49e-05	3.05e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—malignant glioma	1.48e-05	3.03e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.47e-05	3e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—malignant glioma	1.47e-05	3e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—malignant glioma	1.46e-05	2.98e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—malignant glioma	1.45e-05	2.97e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—malignant glioma	1.45e-05	2.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—malignant glioma	1.45e-05	2.97e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—malignant glioma	1.44e-05	2.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—malignant glioma	1.44e-05	2.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—malignant glioma	1.44e-05	2.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—malignant glioma	1.43e-05	2.94e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—malignant glioma	1.41e-05	2.88e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—malignant glioma	1.36e-05	2.79e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—malignant glioma	1.35e-05	2.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—malignant glioma	1.34e-05	2.74e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—malignant glioma	1.33e-05	2.72e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—malignant glioma	1.32e-05	2.71e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—malignant glioma	1.32e-05	2.69e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—malignant glioma	1.31e-05	2.68e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—malignant glioma	1.28e-05	2.63e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—malignant glioma	1.28e-05	2.62e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—malignant glioma	1.25e-05	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—malignant glioma	1.24e-05	2.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—malignant glioma	1.24e-05	2.54e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—malignant glioma	1.22e-05	2.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—malignant glioma	1.2e-05	2.46e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—malignant glioma	1.19e-05	2.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOR1—malignant glioma	1.18e-05	2.41e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—malignant glioma	1.14e-05	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—malignant glioma	1.11e-05	2.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—malignant glioma	1.1e-05	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—malignant glioma	1.08e-05	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—malignant glioma	1.02e-05	2.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAV1—malignant glioma	9.61e-06	1.97e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—malignant glioma	9.3e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CG—malignant glioma	8.75e-06	1.79e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—malignant glioma	8.45e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CD—malignant glioma	7.7e-06	1.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CB—malignant glioma	6.71e-06	1.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—malignant glioma	6.65e-06	1.36e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTEN—malignant glioma	5.8e-06	1.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—malignant glioma	4.09e-06	8.37e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—malignant glioma	3.34e-06	6.84e-06	CbGpPWpGaD
